21 – 30 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Interaction between VWF and FVIII in treating VWD
- Contribution to journal › Article
-
Mark
Non-genetic risk factors and their influence on the management of patients in the clinic
- Contribution to journal › Scientific review
-
Mark
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies
- Contribution to journal › Scientific review
-
Mark
Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
- Contribution to journal › Scientific review
-
Mark
One-stage vs. chromogenic assays in haemophilia A
- Contribution to journal › Scientific review
-
Mark
Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan-two case studies.
(2015) In European Journal of Haematology
- Contribution to journal › Article
- 2014
-
Mark
Methods for individualising factor VIII dosing in prophylaxis
- Contribution to journal › Scientific review
-
Mark
On-demand treatment in persons with severe haemophilia
- Contribution to journal › Scientific review
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
- Contribution to journal › Scientific review
-
Mark
Outcome measures in haemophilia: a systematic review
- Contribution to journal › Scientific review
